Trump says all 50 states will join Medicaid drug model

All states joining the model

President Donald Trump announced that all 50 states will participate in his administration’s Medicaid prescription drug pricing model. The administration calls the program the Medicaid GENEROUS model and says it will reduce what Medicaid pays for prescription drugs.

The announcement gives the model nationwide participation at the state level. The administration claims the resulting price arrangements will save Medicaid billions of dollars, but it has not attached a specific public savings figure to that claim.

Participation by every state establishes the model’s reach, but it does not by itself show how much drug prices or Medicaid spending will change. Those results will depend on the terms of the pricing agreements and how they affect prescription drug costs.

Savings remain uncertain

Experts say the potential savings are unclear because the contents of the agreements have not been made public. Without those terms, the administration’s claim of billions of dollars in savings cannot be independently measured against the prices Medicaid otherwise would have paid.

The distinction is important: the announcement confirms that every state is joining, while the financial outcome remains an administration projection. Public disclosure of the agreements would make it possible to examine the prices, compare them with existing costs and determine whether the model produces the savings the administration has described.

The program concerns Medicaid drug spending rather than a campaign or election. Its next measurable effects will come from the pricing terms and the savings recorded as the model is carried out across all 50 states.